Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger CCHC domain-containing protein 2 (ZCCHC2) is a member of the zinc finger CCHC-type (“zinc knuckle”) superfamily, characterized by a CCHC zinc-binding motif (C-X2-C-X4-H-X4-C). Like other ZCCHC proteins, ZCCHC2 is thought to bind nucleic acids, especially single-stranded RNAs, suggesting a role in RNA metabolism. The broader family is implicated in a variety of RNA regulatory processes, including transcription, splicing, translation, and degradation. However, there is minimal direct functional, disease, or drug interaction annotation for ZCCHC2 specifically, and it is not considered a therapeutic target. Expression profiling suggests a role for ZCCHC2 may be mainly in fundamental cellular RNA processing. Key points: ZCCHC2 is a nuclear zinc finger (CCHC-type) protein with RNA-binding capability. It is not currently a drug target, disease biomarker, or characterized in disease pathogenesis. Its biological function is likely in general RNA metabolism, as inferred from related family proteins.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger CCHC domain-containing protein 2 (ZCCHC2).